Filed a patent for "methods of treating myotonic dystrophy type 1 using peptide-oligonucleotide conjugates" on Thu, June 13, 2024
Filed a patent for "methods of treating duchenne muscular dystrophy using peptide-oligonucleotide conjugates" on Thu, June 20, 2024
